兰索普拉改善了因伊索尼亚齐德诱导的肝损伤
Eri Wakai1, Takashi Shiromizu1,2, Shota Otaki1
1Department of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.
兰索普拉可能会防止因常见的结核病药物异化物引起的肝损伤. 这项研究确定了因异胺诱导的肝损伤的基因特征,并发现了兰索普拉.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 基因组学就是基因组学.
背景情况:
- 伊索尼亚是关键的第一线抗结核药物.
- 异化的使用与药物诱导性肝损伤 (DILI) 的显著风险有关,可能导致肝衰竭.
- 目前缺乏对异尼胺诱导的DILI的预防策略.
研究的目的:
- 为了识别异化物诱导的肝损伤的基因表达特征.
- 预测潜在的治疗药物,以预防异化诱导的肝损伤.
- 为了验证预测药物对异化诱导的肝损伤的保护作用.
主要方法:
- 对公共转录组数据集的分析,以确定基因表达特征.
- 连接映射和不良事件报告系统的应用用于药物预测.
- 使用斑马鱼模型进行体内验证,并对患者电子健康记录进行回顾性分析.
主要成果:
- 鉴定出一种独特的基因表达特征,用于异化诱导的肝损伤.
- 兰索普拉被预测为一种潜在的保护剂,可以防止异化诱导的肝损伤.
- 实验验证证证实了兰索普拉在斑马鱼和患者数据中的保护作用.
结论:
- 兰索普拉在改善异酸诱导的肝损伤方面显示出潜在的潜力.
- 该研究强调了一种综合性方法,用于药物重新定位和识别新药功能.
- 这种方法可用于发现现有药物的新治疗用途.
更多相关视频
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Treatment of Ulcerative Colitis in IBD
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
